✦ LIBER ✦
Delayed initiation of front-line imatinib therapy predicts for poor response to nilotinib as second-line treatment of imatinib-resistant or intolerant CML: single center report of the ENACT trial in Lebanon
✍ Scribed by Zaher K. Otrock, Rami A. Mahfouz, Zahera Fahed…
- Book ID
- 120955176
- Publisher
- Carden Jennings Publishing
- Year
- 2012
- Tongue
- English
- Weight
- 167 KB
- Volume
- 96
- Category
- Article
- ISSN
- 0925-5710
No coin nor oath required. For personal study only.